Close Menu

NEW YORK (GenomeWeb) – Entasis Therapeutics, a spinoff of AstraZeneca, has signed an agreement with BioMérieux to incorporate BioFire FilmArray diagnostic tests into upcoming clinical trials. The multiplex pneumonia panel will be used in trials for a drug to combat carbapenem-resistant A. baumannii infections.

Terms of the deal were not disclosed. Under the agreement, the BioFire FilmArray Pneumonia panel and instruments will be used in the global Phase III trial beginning in Q1 2019 to optimize enrollment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.